US-based retailer Costco Wholesale is facing a proposed US class action alleging undisclosed salmonella risks at a Nebraska chicken plant. A complaint lodged in Seattle federal court claims that salmonella contamination at Costco’s chicken processing facility in Fremont was not disclosed to consumers purchasing Kirkland Signature rotisserie chicken. Filed by Lisa Taylor of Missouri, the suit claims she bought Costco rotisserie chickens monthly and overpaid due to undisclosed contamination risks. The la ...

Core Viewpoint - Becton, Dickinson and Company (BDX) has issued an urgent update regarding its esophagogastric balloon tamponade tubes due to safety concerns following one reported death and two serious injuries related to the device's use [1][2][4]. Company Update - The FDA has highlighted BD's updated instructions for the device, emphasizing potential hazards and the importance of proper usage procedures [2][6]. - BD has a market capitalization of $49.59 billion and an earnings yield of 8.1%, which is higher than the industry average of 5.3% [5]. Stock Performance - Following the announcement, BDX shares traded flat until Thursday's closing, with a year-to-date decline of 23.4%, compared to the industry's 0.8% decline and the S&P 500's 0.3% loss [3]. Safety Concerns - The FDA's safety communication was prompted by issues with the device during the pre-use phase, particularly difficulties in removing plastic plugs, which could damage the device [6][8]. - Complications from these issues could delay diagnosis or treatment, potentially worsening patient outcomes [8]. Response Measures - In response to the incidents, BD has communicated revised preparation steps to customers, including specific methods for safely removing plugs from the device [9][10]. - BD is reinforcing training across healthcare facilities and reviewing product handling instructions to enhance patient safety [10].